A proinflammatory role of type 2 innate lymphoid cells in murine immune-mediated hepatitis

Journal of Immunology

Volumn 198, Issue 1, 2017, Pages 128-137

  Neumann, Katrin ^a   Karimi, Khalil ^a   Meiners, Jana ^a   Voetlause, Ruth ^a   Steinmann, Silja ^a   Dammermann, Werner ^a   Lüth, Stefan ^a   Asghari, Farahnaz ^a   Wegscheid, Claudia ^a   Horst, Andrea K ^a   Tiegs, Gisa ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CONCANAVALIN A; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 5; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; CYTOKINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; EFFECTOR CELL; GENE EXPRESSION REGULATION; HEPATITIS B; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LEUKOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TYPE 2 INNATE LYMPHOID CELL; UPREGULATION; ANIMAL; AUTOIMMUNE HEPATITIS; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; REAL TIME POLYMERASE CHAIN REACTION;

ADOPTIVE TRANSFER; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-33; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 85007009737     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600418     Document Type: Article

References (43)

1. Carbone, M., and J. M. Neuberger. 2014. Autoimmune liver disease, autoimmunity and liver transplantation. J. Hepatol. 60: 210-223.
2. Oo, Y. H., S. G. Hubscher, and D. H. Adams. 2010. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol. Int. 4: 475-493.
3. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90: 196-203.
4. Wang, H. X., M. Liu, S. Y. Weng, J. J. Li, C. Xie, H. L. He, W. Guan, Y. S. Yuan, and J. Gao. 2012. Immune mechanisms of concanavalin A model of autoimmune hepatitis. World J. Gastroenterol. 18: 119-125.
5. Erhardt, A., and G. Tiegs. 2010. Tolerance induction in response to liver inflammation. Dig. Dis. 28: 86-92.
6. Küsters, S., F. Gantner, G. Künstle, and G. Tiegs. 1996. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111: 462-471.
7. Robinson, R. T., J. Wang, J. G. Cripps, M. W. Milks, K. A. English, T. A. Pearson, and J. D. Gorham. 2009. End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas. J. Immunol. 182: 3278-3284.
8. Gantner, F., M. Leist, A. W. Lohse, P. G. Germann, and G. Tiegs. 1995. Concanavalin A-induced T cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190-198.
9. Gao, B., W. I. Jeong, and Z. Tian. 2008. Liver: an organ with predominant innate immunity. Hepatology 47: 729-736.
10. Lang, K. S., A. Burow, M. Kurrer, P. A. Lang, and M. Recher. 2007. The role of the innate immune response in autoimmune disease. J. Autoimmun. 29: 206-212.
11. Sonnenberg, G. F., and D. Artis. 2015. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat. Med. 21: 698-708.
12. Walker, J. A., J. L. Barlow, and A. N. McKenzie. 2013. Innate lymphoid cells - how did we miss them? Nat. Rev. Immunol. 13: 75-87.
13. Spits, H., D. Artis, M. Colonna, A. Diefenbach, J. P. Di Santo, G. Eberl, S. Koyasu, R. M. Locksley, A. N. McKenzie, R. E. Mebius, et al. 2013. Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 13: 145-149.
14. Fallon, P. G., S. J. Ballantyne, N. E. Mangan, J. L. Barlow, A. Dasvarma, D. R. Hewett, A. McIlgorm, H. E. Jolin, and A. N. McKenzie. 2006. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203: 1105-1116.
15. Chang, Y. J., H. Y. Kim, L. A. Albacker, N. Baumgarth, A. N. McKenzie, D. E. Smith, R. H. Dekruyff, and D. T. Umetsu. 2011. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12: 631-638.
16. Motomura, Y., H. Morita, K. Moro, S. Nakae, D. Artis, T. A. Endo, Y. Kuroki, O. Ohara, S. Koyasu, and M. Kubo. 2014. Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation. Immunity 40: 758-771.
17. McHedlidze, T., M. Waldner, S. Zopf, J. Walker, A. L. Rankin, M. Schuchmann, D. Voehringer, A. N. McKenzie, M. F. Neurath, S. Pflanz, and S. Wirtz. 2013. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39: 357-371.
18. Cayrol, C., and J. P. Girard. 2014. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol. 31: 31-37.
19. Nussbaum, J. C., S. J. Van Dyken, J. von Moltke, L. E. Cheng, A. Mohapatra, A. B. Molofsky, E. E. Thornton, M. F. Krummel, A. Chawla, H. E. Liang, and R. M. Locksley. 2013. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502: 245-248.
20. Roediger, B., R. Kyle, K. H. Yip, N. Sumaria, T. V. Guy, B. S. Kim, A. J. Mitchell, S. S. Tay, R. Jain, E. Forbes-Blom, et al. 2013. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat. Immunol. 14: 564-573.
21. Maizels, R. M., J. P. Hewitson, and K. A. Smith. 2012. Susceptibility and immunity to helminth parasites. Curr. Opin. Immunol. 24: 459-466.
22. Wang, J., P. Zhao, H. Guo, X. Sun, Z. Jiang, L. Xu, J. Feng, J. Niu, and Y. Jiang. 2012. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C. Mediators Inflamm. 2012: 819636.
23. Sun, Y., J. Y. Zhang, S. Lv, H. Wang, M. Gong, N. Du, H. Liu, N. Zhang, J. Jing, C. Zhou, et al. 2014. Interleukin-33 promotes disease progression in patients with primary biliary cirrhosis. Tohoku J. Exp. Med. 234: 255-261.
24. Marvie, P., M. Lisbonne, A. L'helgoualc'h, M. Rauch, B. Turlin, L. Preisser, K. Bourd-Boittin, N. Théret, H. Gascan, C. Piquet-Pellorce, and M. Samson. 2010. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J. Cell. Mol. Med. 14(6B): 1726-1739.
25. Chen, J., L. Duan, A. Xiong, H. Zhang, F. Zheng, Z. Tan, F. Gong, and M. Fang. 2012. Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-g production in mice. J. Mol. Med. 90: 1505-1515.
26. Erhardt, A., M. Biburger, T. Papadopoulos, and G. Tiegs. 2007. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 45: 475-485.
27. Schiering, C., T. Krausgruber, A. Chomka, A. Fröhlich, K. Adelmann, E. A. Wohlfert, J. Pott, T. Griseri, J. Bollrath, A. N. Hegazy, et al. 2014. The alarmin IL-33 promotesregulatory T-cell function in the intestine. Nature 513: 564-568.
28. Hoyler, T., C. S. Klose, A. Souabni, A. Turqueti-Neves, D. Pfeifer, E. L. Rawlins, D. Voehringer, M. Busslinger, and A. Diefenbach. 2012. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37: 634-648.
29. Chauvet, C., B. Bois-Joyeux, and J. L. Danan. 2002. Retinoic acid receptor-related orphan receptor (ROR) alpha4 is the predominant isoform of the nuclear receptor RORalpha in the liver and is up-regulated by hypoxia in HepG2 human hepatoma cells. Biochem. J. 364: 449-456.
30. Salimi, M., J. L. Barlow, S. P. Saunders, L. Xue, D. Gutowska-Owsiak, X. Wang, L. C. Huang, D. Johnson, S. T. Scanlon, A. N. McKenzie, et al. 2013. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J. Exp. Med. 210: 2939-2950.
31. Monticelli, L. A., G. F. Sonnenberg, M. C. Abt, T. Alenghat, C. G. Ziegler, T. A. Doering, J. M. Angelosanto, B. J. Laidlaw, C. Y. Yang, T. Sathaliyawala, et al. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12: 1045-1054.
32. Cortez, V. S., M. L. Robinette, and M. Colonna. 2015. Innate lymphoid cells: new insights into function and development. Curr. Opin. Immunol. 32: 71-77.
33. Mjösberg, J., J. Bernink, K. Golebski, J. J. Karrich, C. P. Peters, B. Blom, A. A. te Velde, W. J. Fokkens, C. M. van Drunen, and H. Spits. 2012. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37: 649-659.
34. Klein Wolterink, R. G., N. Serafini, M. van Nimwegen, C. A. Vosshenrich, M. J. de Bruijn, D. Fonseca Pereira, H. Veiga Fernandes, R. W. Hendriks, and J. P. Di Santo. 2013. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Proc. Natl. Acad. Sci. USA 110: 10240-10245.
35. Louis, H., A. Le Moine, V. Flamand, N. Nagy, E. Quertinmont, F. Paulart, D. Abramowicz, O. Le Moine, M. Goldman, and J. Devière. 2002. Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology 122: 2001-2010.
36. Spencer, S. P., C. Wilhelm, Q. Yang, J. A. Hall, N. Bouladoux, A. Boyd, T. B. Nutman, J. F. Urban, Jr., J. Wang, T. R. Ramalingam, et al. 2014. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 343: 432-437.
37. Neill, D. R., S. H. Wong, A. Bellosi, R. J. Flynn, M. Daly, T. K. Langford, C. Bucks, C. M. Kane, P. G. Fallon, R. Pannell, et al. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370.
38. Halim, T. Y., R. H. Krauss, A. C. Sun, and F. Takei. 2012. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36: 451-463.
39. Bartemes, K. R., K. Iijima, T. Kobayashi, G. M. Kephart, A. N. McKenzie, and H. Kita. 2012. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 188: 1503-1513.
40. Gieseck III, R. L., T. R. Ramalingam, K. M. Hart, K. M. Vannella, D. A. Cantu, W. Y. Lu, S. Ferreira-González, S. J. Forbes, L. Vallier, and T. A. Wynn. 2016. Interleukin-13 activates distinct cellular pathways leading to ductular reaction, steatosis, and fibrosis. Immunity 45: 145-158.
41. Tang, J., H. Huang, X. Ji, X. Zhu, Y. Li, M. She, S. Yan, M. Fung, and Z. Li. 2014. Involvement of IL-13 and tissue transglutaminase in liver granuloma and fibrosis after schistosoma japonicum infection. Mediators Inflamm. 2014: 753483.
42. Matta, B. M., J. M. Lott, L. R. Mathews, Q. Liu, B. R. Rosborough, B. R. Blazar, and H. R. Turnquist. 2014. IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. J. Immunol. 193: 4010-4020.
43. Vasanthakumar, A., K. Moro, A. Xin, Y. Liao, R. Gloury, S. Kawamoto, S. Fagarasan, L. A. Mielke, S. Afshar-Sterle, S. L. Masters, et al. 2015. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat. Immunol. 16: 276-285.